Wed, March 3, 2021
Tue, March 2, 2021
Mon, March 1, 2021

Graig Suvannavejh Initiated (TERN) at Strong Buy and Held Target at $29 on, Mar 2nd, 2021

Graig Suvannavejh of Goldman Sachs, Initiated "Terns Pharmaceuticals, Inc." (TERN) at Strong Buy and Held Target at $29 on, Mar 2nd, 2021.

Graig, nor any peers, have made any analyst calls on TERN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30